Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 206

Support Domestic Sequencing Instruments

2,659 words 9 min read 2 views 4mo ago Source ​
Skip to the end of the chapter
Prev
Next

Wei Kang hurriedly entered the office.

"Anmei, help me look up all the information about Daxia Intelligent Manufacturing."

"Okay." A sweet female voice came through the Bluetooth headset. "Let me first introduce you to Daxia Intelligent Manufacturing Company..."

"Daxia Intelligent Manufacturing is the leading company in upstream equipment R&D for gene sequencing in China. According to public information, the company's revenue has grown at a compound annual growth rate of over 200% in the past three years. It holds about one-third of the domestic Gene Sequencer market share and has more than 1,100 units installed globally, covering 16 countries and regions, with more than 300 users."

"Gene sequencing technology has evolved from first-generation sequencing to fourth-generation sequencing technology. However, because each of these four generations of sequencing technology has its own advantages and disadvantages and is applied in different fields, first-generation sequencing technology has not been eliminated. The current sequencing market is dominated by four generations of sequencing technology, with second-generation NGS sequencing technology being the mainstay overall."

"Currently, Daxia Intelligent Manufacturing and Illumina are competing in the second-generation NGS sequencing technology market. Although Daxia Intelligent Manufacturing is developing well, its profit margin cannot be compared with Illumina. The reason is that its sequencing equipment is mainly supplied to its parent group Daxia Gene, and its related companies for sequencing services."

"The two sides are actually two sides of the same development of Daxia Group. The former produces sequencing equipment, while the latter undertakes the former to provide sequencing services to the market. Without the support of Daxia Gene, Daxia Intelligent Manufacturing would not be where it is today."

Wei Kang suddenly asked, "What is the biggest risk of this company right now? Are there any scandals? This is something I need to carefully consider if we want to reach a long-term strategic cooperation."

"There are two main risks. One is the listing issue. Daxia Intelligent Manufacturing has been applying for an IPO on the STAR Market, but it has been delayed. The main reason is the related-party transactions with Daxia Gene, which has been questioned by many securities practitioners and the media. Several times, the listing application has been suspended by the exchange on the grounds of missing materials."

"If the listing goes smoothly, Daxia Intelligent Manufacturing will raise more than 2 billion yuan, which will greatly promote technology and sales. Otherwise, relying solely on Daxia Gene's support will inevitably make people lack confidence in its future development."

"Secondly, the company is also mired in litigation, having faced a series of patent lawsuits from its Illumina, in recent years."

"Illumina has initiated protracted patent lawsuits against Daxia Intelligent Manufacturing and its subsidiaries, distributors and customers overseas. The countries and regions involved include the Eagle Country, Europa and 12 other countries and regions. In these lawsuits, Daxia Intelligent Manufacturing lost some cases and its related products were banned from sale, some cases were dismissed and some cases are still under trial."

"It is still unknown when Daxia Intelligent Manufacturing will be able to extricate itself from the quagmire of litigation. However, it is foreseeable that if these marathon patent lawsuits are not dealt with as soon as possible, they will definitely bring greater risks to the company in the future."

"Furthermore, the owner of Daxia Gene controls 53% of Daxia Intelligent Manufacturing's shares, and this owner has an extreme reputation, resulting in a very poor reputation for Daxia Gene, with numerous scandals. Online data also shows that Daxia Group offers the lowest salaries in the industry, leading to a mass exodus of employees and an inability to retain truly talented individuals. These are all risks that need to be considered."

Wei Kang couldn't help but wonder, "Lowest salary in the entire industry? Just how low?"

"Shenzhen Exchange headquarters, 3000 for undergraduates."

"This..." Wei Kang was stunned. "Good heavens, this is even lower than the sweatshop of a certain Fukang."

"Wang Qing, the boss of Daxia Gene, is 69 years old. He graduated from junior high school and started from scratch. He likes to talk big and is good at capital operation. After Daxia Gene went public, the stock price rose from 20 yuan to 300 yuan, but now it has fallen back down."

Anmei is constantly supplementing the information she has collected.

"While the company's stock price fluctuated, Old Man Wang reduced his holdings by more than 20%, making a fortune. Moreover, he very cunningly applied for a separate listing for the company's most valuable asset, Daxia Intelligent Manufacturing. His intentions are obvious."

Overall, Daxia Intelligent Manufacturing received a B- rating, Daxia Gene received a D rating.

Wei Kang shook his head. "A 70-year-old leader like him would definitely have a generation gap with me. It's not that I'm prejudiced against him, it's just that a boss with only a junior high school education wants to run a high-tech company, it just doesn't seem reliable."

"You're right. I have some of his deeds here that might be helpful for your decision-making."

"Wang Qing claims that the ultimate goal of Daxia Gene is immortality. He once proposed that everyone can live to 100 years old, while he can live to 120 years old. He also insists that he has achieved significant reverse aging. When the photos are taken, he looks younger at 70 than at 50. This miracle even went viral on social media."

"He traveled around advocating that saving money is not as good as saving life, and that saving one's own cells is better than storing 50 years' Maotai. He tried his best to persuade the rich across the country to invest in the technology field of 'extending lifespan,' which is Daxia Group."

Wei Kang couldn't help but click his tongue and say, "Tsk tsk, Old Man Wang is truly a master of hype. I am ashamed of myself."

He stroked his chin and pondered, "Now that you mention it, I feel even more that this company is putting on a show, and I'm starting to doubt whether we should continue our long-term cooperation with Daxia Intelligent Manufacturing."

"However, if we really want to use domestically produced sequencers, there is currently no other choice but Daxia Intelligent Manufacturing, which has become a leading company."

"By the way, what do Daxia Intelligent Manufacturing's customers think of its products?"

"The advantage of Daxia Intelligent Manufacturing's sequencing instruments lies in their ability to significantly reduce costs while maintaining the same DNA fragment read length and yield."

"Last year, a research team from Stick Country published a research article in the journal Genetics, analyzing and comparing the performance of sequencers from Daxia Intelligent Manufacturing and Illumina at the whole genome sequencing level."

"Researchers used a sequencer to sequence normal and tumor tissues from lung cancer patients in Stick Country and made parallel comparisons of the resulting data. By evaluating the raw data from the two platforms, they found that both showed similar quality and genome coverage depth at the quality control level."

"At the same time, the research team compared the whole genome sequence with the reference genome, and the results showed that the coverage of all samples was above 99.9%. The sequencing results of the two sequencers were very similar, with a high overlap rate, at 92.0% and 93.0% for each sample, respectively."

"With the support of data from multiple sources, the research team believes that both platforms provide high-quality sequencing data and sufficient genome coverage, are suitable for whole-genome sequencing analysis, and have a high degree of consistency in sequencing performance, which indicates that the performance of both platforms has reached the international leading level."

"In addition, Ruiji Hospital and Jingda Cancer Hospital in China have used Daxia Intelligent Manufacturing's sequencing platform to perform gene sequencing on Cancer patients and published articles in journals such as 'Cell'."

"There are also dozens of other papers that have been published using the Daxia Intelligent Manufacturing Sequencing Instrument."

"This shows that Daxia Intelligent Manufacturing's sequencers have been successfully applied to research in multiple fields."

Wei Kang couldn't help but nod, then hesitated and said, "Although Daxia Intelligent Manufacturing and Daxia Gene are from the same group and have the same boss, they are still quite different. How about this, let's buy a few to try out first, as long as the machines work well."

"Your decision is very wise. However, Anmei would like to remind you that although Second-Generation Sequencing technology is currently the mainstream, third-generation Single-Molecule Sequencing technology and fourth-generation nanopore sequencing technology are developing rapidly and have begun to be applied in clinical and scientific research."

"Compared to second-generation sequencing, third- and fourth-generation sequencers have the advantages of longer read lengths and lower costs, bringing the cost of a single whole-genome sequencing session down to below $100. At the same time, they can detect longer gene fragments at a time, and the sequencing speed is also greatly improved. Fourth-generation technology can compress the time to less than 4 hours, while Second-Generation Sequencing takes several days to complete."

"The only drawback is that the technology is not mature enough to achieve a satisfactory sequencing accuracy, which is about 86%. It cannot be used independently and can only be used as a supplement to Second-Generation Sequencing in most cases."

Wei Kang said with some delight, "This is indeed excellent. We can also import a batch of fourth-generation sequencers to supplement our needs. By the way, are there any companies that offer fourth-generation sequencers?"

"The Oxford Nanopore Technologies abroad has more mature technology in this area. The company is already listed and has mass-produced a highly anticipated handheld Nanopore sequencer that can be used in extreme environments such as space. It has also deciphered the Ebola virus sequence at the fastest speed."

"In addition, scientists in Antarctica, where there is no internet or laboratory facilities, completed real-time gene sequencing using only a mini handheld device and a portable computer."

Wei Kang shook his head. "This is also a foreign company, and the only one of its kind. We can't accept it. Are there any Nanopore sequencer companies in China?"

"Domestically, only one company called Carbon-based has released the first nanopore Gene Sequencer, which is about to enter mass production and be launched on the market."

Wei Kang couldn't help but feel a little disappointed. "It's about to be mass-produced, but it's not yet mass-produced. Let's wait a little longer."

He thought for a moment and then said, "Actually, the fourth-generation Nanopore sequencer is very suitable for shared laboratories. We can still buy a few to try."

He then sent instructions to Zhao Xiaojie, requesting that each of the two companies purchase several sequencers and send them to the R&D department for trial use.

After receiving the instructions, Zhao Xiaojie wiped the sweat from his forehead and began running around non-stop again.

Qi Jun, the president of the Carbon-based Company, was also very pleasantly surprised after receiving the inquiry call.

He took out his phone and began to talk at length about his company's products.

"Mr. Zhao, thank you very much for your call. At the end of last year, we invested 200 million yuan to establish a production base in Shu City, and we plan to put it into production as well as a series of products such as nanopore Gene Sequencer and reagent kits. The annual output can reach 2,000 units, and the supporting testing reagents can be used for 1 million people."

"Welcome to Shu City for inspection. In the past year, we have carried out close cooperation with local institutions such as Sichuan University and Shuxi Hospital in the fields of infection diagnosis, forensic identification, and tumor research."

"You can see these cooperation cases in our company. Currently, the best feedback from our clients is in the field of forensic medicine."

"DNA testing is widely used in forensic laboratories around the world to solve criminal cases, and our portable Nanopore sequencer is very suitable for crime scene analysis with an accuracy rate of up to 99.8%, and it has recently begun to emerge in this field."

"In the scientific research field, nanopore assays are mainly used for sequencing viruses or bacteria because their genomes are much smaller than those of humans, but they also have great potential in large-scale human whole-genome sequencing."

"In this regard, we also have research collaborations with many hospitals, and the feedback from our clients has been very positive."

"Don't worry, our first batch of mass-produced machines will be available next week, and we will send them to Three Purities for trial use as soon as possible."

The two parties reached an agreement on the first batch of orders smoothly.

Handheld sequencers are very cheap; foreign products cost only $1,000 each, while domestic products cost less than 5,000 yuan. So Zhao Xiaojie ordered ten units at once, and they will be officially shipped after the contract is signed.

Zhao Xiaojie put down his dead phone, rubbed his temples, and felt parched and exhausted.

He spent the whole day on the phone, constantly communicating with the CEOs of the two companies, and finally managed to finalize the two orders within a single day.

I'm just waiting to fly over on Monday to inspect the factory and then sign the contract.

He runs between two companies, one in Shu City and the other in Shenzhen. He must be exhausted from visiting one of them every day.

But there was nothing he could do; he hadn't done a good job with risk control and contingency plans, and he almost messed things up.

Those Illumina, those damned Eagle Country, they're utterly despicable, shameless, and vile.

Hopefully, these two domestically produced testing instruments can step up and satisfy President Wei.

He silently poured himself a cup of strong tea, turned on his computer, and prepared to continue his hard work.

There's also a list of equipment that needs to be fully domestically produced that needs to be finalized this week.

******

At 8:15, Huang Qin hurriedly entered the Gene Laboratory located on the 11th floor of the Pangu Building.

After developing several Gene Drug, the Biology Laboratory established a dedicated Gene Laboratory, mainly to develop drugs for single-gene diseases.

Huang Qin is as diligent and eager to learn as his name suggests. He has been working with all-around PhD experts like Williams, so he has made rapid progress and has been promoted to a research and development team leader.

His best friend Williams also got promoted to deputy team leader, and he's still in the same team as him.

The two worked together very well and were considered a golden combination, making them well-known throughout the entire Biology Laboratory.

After all, it's quite eye-catching to see two people with completely opposite appearances—one tall and one short, one strong and one thin—spending all their time together and going in and out of the same place.

What puzzled him was that such a capable person as Williams was only promoted to deputy team leader and his assistant. He thought the leader was really bad at recognizing talent.

He felt somewhat ashamed because, in their daily work, the other person made greater contributions and also had a higher level of education than him.

It might be racial discrimination. Three Purities is, after all, a China company, and they prefer to cultivate their own people. Foreigners don't get promoted as quickly as their own. Besides, Williams is a postdoctoral fellow with a bright future. He might leave after a few years and might not stay.

That was the only way he could console himself.

I had just sat down in the office when I heard Williams call out to me.

"Qin, come here quickly. The lab has just installed a few Gene Sequencer manufactured in China. Let's go try them out and see how they differ from Illumina's sequencing platform."

Williams speaks fluent Chinese without any foreign accent, but when he pronounces the word "qin," there is a slight change in tone, making it sound more like the familiar term "qin."

This nickname made Huang Qin both amused and exasperated. Ever since Williams started calling him that, all his colleagues in the lab have begun to address him as "dear" like Taobao Xiao Er (a popular online personality).

The problem is, it feels a bit strange coming from Williams, a tall, bearded man who's 1.8 meters tall. Something seems off, like there's a hint of homoeroticism about it. Even the new, beautiful female colleague looked at him strangely after hearing it.

Huang Qin responded, put on a white coat, and followed Williams into the laboratory.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Wei Kang
Three Purities
China
Eagle Country
Huang Qin

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS